Article Details
Retrieved on: 2025-04-04 12:56:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses biotechnology firm Sernova's advancement in cell therapy for type 1 diabetes using its Cell Pouch Bio-hybrid Organ. It connects to the key concept 'Biotechnology' and relates to tags like 'Stem cells', 'Cell therapy', and 'Diabetes'. Tags such as 'Pancreatic islets' and 'Insulin' highlight its focus on insulin independence through islet transplantation. Jonathan Rigby, the CEO, comments on trial progress within the United States.
Article found on: www.streetwisereports.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here